Ignite Creation Date:
2024-05-06 @ 10:21 AM
Last Modification Date:
2024-10-26 @ 12:28 PM
Study NCT ID:
NCT03233516
Status:
COMPLETED
Last Update Posted:
2020-11-23
First Post:
2017-07-26
Brief Title:
Trial of Respiratory Infections in Children for Enhanced Diagnostics
Sponsor:
Organization:
Karolinska Institutet
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
10 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
capillary lithium-heparin tube will be separated into two aliquots and diluted in a commercial buffer
capillary point-of-care test CRP
nasopharyngeal swab for Mari-POC diluted in 13ml MariPOC RTI buffer
nasopharyngeal aspirate diluted into 13ml saline divided into three aliquots
1 Real-time PCR-analysis of respiratory agents 400μl
2 Frozen down at -80C for study IV 400μl
3 Available for routine microbiological testing as ordered by the attending physician If not used frozen down at -80C for potential reanalyses 500μl
All samples will be taken within 24h from arrival at the emergency unit and time for both blood and nasopharynx samples will be registered It will also be noted if antibiotics have been given before samples taken
Enrollment Count:
376
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Control |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 42787 |
Who Masked List: